Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beuzeboc

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Immunology Letters|July 1, 1997
IL-6 is a survival prognostic factor in renal cell carcinomaN Thiounn, F Pages, T Flam, et al.
Bulletin Du Cancer|January 1, 1989
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials]M Jouve, T Palangie, L Belli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 13, 2002
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]D Nguyen, A de la Rochefordière, L Chauveinc, et al.
Gynecologic Oncology|August 1, 1997
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinomaJ Y Pierga, V Diéras, P Beuzeboc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancerR P Abratt, D Brune, M-A Dimopoulos, et al.
Cancer Research|January 15, 1990
Presence of villin, a tissue-specific cytoskeletal protein, in sera of patients and an initial clinical evaluation of its value for the diagnosis and follow-up of colorectal cancersB Dudouet, L Jacob, P Beuzeboc, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
La Clinica Terapeutica|November 28, 1997
First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancerE Garcia-Giralt, C Omodei Zorini, P Beuzeboc, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Immunology Letters|July 1, 1997
IL-6 is a survival prognostic factor in renal cell carcinomaN Thiounn, F Pages, T Flam, et al.
Bulletin Du Cancer|January 1, 1989
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials]M Jouve, T Palangie, L Belli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 13, 2002
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]D Nguyen, A de la Rochefordière, L Chauveinc, et al.
Gynecologic Oncology|August 1, 1997
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinomaJ Y Pierga, V Diéras, P Beuzeboc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancerR P Abratt, D Brune, M-A Dimopoulos, et al.
Cancer Research|January 15, 1990
Presence of villin, a tissue-specific cytoskeletal protein, in sera of patients and an initial clinical evaluation of its value for the diagnosis and follow-up of colorectal cancersB Dudouet, L Jacob, P Beuzeboc, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
La Clinica Terapeutica|November 28, 1997
First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancerE Garcia-Giralt, C Omodei Zorini, P Beuzeboc, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
Pageof 14